Local News: Los Angeles, CA 

 | 

Sign Up

 | 

Sign In

VIVUS News Editors

News Widget

Display the VIVUS news headlines on your website.

Get the Topix Headlines Widget

Share & bookmark

RSS icon mobile icon

VIVUS News

News on VIVUS (Ticker: VVUS) continually updated from thousands of sources around the net.

5 hrs ago | Seeking Alpha

These Biotechs May Break Out While Vivus And Arena Battle It Out

For a variety of reasons the following biotech stocks may break-out if general Market conditions do not impede that possibility.

Comment?

Related Topix: Startups, SuperGen, Personal Finance, Day Trading

Sun May 27, 2012

Seeking Alpha

Best Performing Stocks In 2012

The Russell 3,000 is currently up 4.97% year to date, yet the average stock in the index is up 3.98% so far in 2012.

Comment?

Related Topix: Financial Markets, Startups

Fri May 25, 2012

Seeking Alpha

Bio-Pharma Stocks To Watch For Next Week

Going into a four-day weekend many traders do not like to hold stocks. Personally, I am 50/50 on this one as the extra day often times can help when faced with a choppy overall market that we are in now.

Comment?

Related Topix: Prostate Cancer, Health, Brain Cancer, Medicine, Liver Cancer, Breast Cancer, Esophageal Cancer, Startups

Fri May 11, 2012

Seeking Alpha

Threshold Pharmaceutical's TH-302 Could Be A Blockbuster By Targeting Hypoxia In Cancer

Without question, Threshold Pharmaceuticals, Inc. is on the cusp of becoming a blockbuster stock for those of you following the new developments, their pipeline, orphan drug status, EU approval, and discovery into Hypoxia and how it relates to cancer .

Comment?

Related Topix: Startups, Threshold Pharmaceuticals

Seeking Alpha

Hitting The Jackpot With Small Cap Bio Pharma Investment, Part 1

Yesterday, investors who placed their bets on Arena Pharma receiving a favorable recommendation from an FDA advisory committee on lorcaserin hit the small cap bio pharma jackpot.

Comment?

Related Topix: Food and Drug Administration, Startups

Thu May 10, 2012

Bloomberg

Arena Wins FDA Advisory Panel Backing for Obesity Pill

Arena Pharmaceuticals Inc. won the backing of a U.S advisory panel for a weight-loss medicine competing to become the first obesity pill approved in 13 years.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups, Orexigen Therapeutics, US News

IVillage

New Weight-Loss Drug Shows Promise in Trial

THURSDAY, May 10 -- A new weight-loss drug that is awaiting approval from the U.S. Food and Drug Administration showed promising results in a recent international trial, researchers report.

Comment?

Related Topix: Food and Drug Administration, Medicine, Phentermine (generic), Ionamin, Adipex-P, Medication, Topamax, Topiramate (generic), France, World News, Sweden, Startups

Sacramento Bee Newspaper

FDA advisers recommend approving weight loss drug

Advisers to government health regulators on Thursday recommended that that they approve sales of what would be the first new prescription weight-loss drug in the U.S. in more than a decade, despite concerns over cardiac risks.

Comment?

Related Topix: Food and Drug Administration, Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Startups

Seeking Alpha

Arena Pharma Shares Halted Before FDA Advisory Panel Vote On Lorcaserin

As widely expected, Arena Pharma's stock has been halted for trading until the results of a vote from an FDA advisory is known later today whether to recommend Arena's weight loss drug, lorcaserin to the FDA regulators for approval or rejection.

Comment?

Related Topix: Startups

Seeking Alpha

Vivus Will Plummet If Qnexa Fails

Vivus , a biotechnology company that focuses on obesity, diabetes and male sexual health is up roughly 150% year to date.

Comment?

Related Topix: Startups, Healthcare Law, Law

Wed May 09, 2012

Seeking Alpha

5 Biotech Stocks To Buy Now For Gains In 2013

Investors hate to be limited, which is why a selection of choices is always better than just one.

Comment?

Related Topix: Financial Markets, Startups

Tue May 08, 2012

Seeking Alpha

Betting On FDA's Vote For Arena Pharmaceuticals?

Investors of Arena Pharmaceuticals could be twiddling their thumbs nervously over the next couple of days as lorcaserin -- the company's obesity drug candidate -- faces a crucial make-or-break review on May 10, 2012.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Arena Pharmaceuticals, Marketing, Science / Technology, Startups, Orexigen Therapeutics

AmericanBankingNews.com

Needham & Company Reaffirms "Buy" Rating on VIVUS

's stock had its "buy" rating reiterated by investment analysts at Needham & Company in a note issued to investors on Tuesday.

Comment?

Related Topix: Startups, Bank of America, Financial Services, Banking

Seeking Alpha

Prolor's Advantage In The Obesity Drug Race

Obesity is fast becoming America's number one healthcare issue, eating up an increasingly gluttonous percentage of both the Medicare and Medicaid pie.

Comment?

Related Topix: Startups

Mon May 07, 2012

The Washington Post

Electronic Arts, Mako Surgical, Vivus, Wynn: U.S. Equity Preview

Shares of the following companies may have unusual moves in U.S. trading tomorrow.

Comment?

Related Topix: Startups, Electronic Arts, Palo Alto, CA, Science / Technology

Wall St. Cheat Sheet

Racked With Losses, Vivus is Putting All Its Eggs in This Basket

Biopharmaceutical company Vivus is banking big on its newly approved pill that is expected to provide erections within 15 minutes, about half the time of Pfizer's A popular Viagra.

Comment?

Related Topix: Startups, Pfizer, Excaliard Pharmaceuticals, Biotech, Medicine, Healthcare Industry, Foldrx Pharmaceuticals, Eli Lilly

Seeking Alpha

Noteworthy Institutional 5% Ownership Filings In Healthcare In The Past Week-And-A-Half

Many leading funds, including SAC Capital, MFS and GAMCO, filed forms 13-D and 13-G with the SEC on in the past week-and-a-half , indicating that they had amended their ownership in U.S. traded public companies.

Comment?

Related Topix: Startups, Erectile Dysfunction, Medicine, Health, Sarcoma

Seeking Alpha

Preview Of Arena's Upcoming Advisory Committee

On the morning of May 8th, the Food & Drug Administration will release the briefing documents for the May 10th Advisory Committee meeting to discuss the risk and benefit profile of Arena Pharmacueticals' new drug, Lorqess .

Comment?

Related Topix: Food and Drug Administration, Startups

Fri May 04, 2012

Digital Producer

VIVUS to Present at Three Investor Conferences in May

VIVUS, Inc. today announced that Timothy Morris, chief financial officer, will present an overview of the company at three investor conferences during the month of May.

Comment?

Related Topix: Startups, Healthcare Law, Law, Food and Drug Administration, Marketing

Tue May 01, 2012

Seeking Alpha

Arena's Lorcaserin: When Placebos Work Too Well

On May 10, an FDA advisory committee will be trying to balance the effectiveness vs.

Comment?

Related Topix: Healthcare Law, Law, Startups, Life, Food, Nutrition, Dieting

Los Angeles Jobs

Also on Topix